These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 17194172

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. NSAID use in individuals at risk of renal adverse events: an observational study to investigate trends in Australian veterans.
    Roughead EE, Ramsay E, Pratt N, Gilbert AL.
    Drug Saf; 2008; 31(11):997-1003. PubMed ID: 18840019
    [Abstract] [Full Text] [Related]

  • 24. Hyperkalemia in ambulant postcardiac surgery patients during combined therapy with angiotensin-converting enzyme inhibitor, spironolactone, and diet rich in potassium: A report of two cases and review of literature.
    Dixit A, Majumdar G, Tewari P.
    Ann Card Anaesth; 2019; 22(2):162-168. PubMed ID: 30971598
    [Abstract] [Full Text] [Related]

  • 25. Predicting the risk of hyperkalemia in patients with chronic kidney disease starting lisinopril.
    Johnson ES, Weinstein JR, Thorp ML, Platt RW, Petrik AF, Yang X, Anderson S, Smith DH.
    Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):266-72. PubMed ID: 20112435
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Life-threatening hyperkalaemia caused by ACE inhibitor and diuretics.
    Jarman PR, Keheley AM, Mather HM.
    Diabet Med; 1997 Sep; 14(9):808. PubMed ID: 9300234
    [No Abstract] [Full Text] [Related]

  • 31. Patient- and physician-related risk factors for hyperkalaemia in potassium-increasing drug-drug interactions.
    Eschmann E, Beeler PE, Kaplan V, Schneemann M, Zünd G, Blaser J.
    Eur J Clin Pharmacol; 2014 Feb; 70(2):215-23. PubMed ID: 24150532
    [Abstract] [Full Text] [Related]

  • 32. Laboratory monitoring of patients treated with antihypertensive drugs and newly exposed to non steroidal anti-inflammatory drugs: a cohort study.
    Fournier JP, Lapeyre-Mestre M, Sommet A, Dupouy J, Poutrain JC, Montastruc JL.
    PLoS One; 2012 Feb; 7(3):e34187. PubMed ID: 22479557
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers.
    Raebel MA, McClure DL, Simon SR, Chan KA, Feldstein A, Andrade SE, Lafata JE, Roblin D, Davis RL, Gunter MJ, Platt R.
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):55-64. PubMed ID: 16470693
    [Abstract] [Full Text] [Related]

  • 36. Effects of NSAIDs on the incidence of hospitalisations for renal dysfunction in users of ACE inhibitors.
    Bouvy ML, Heerdink ER, Hoes AW, Leufkens HG.
    Drug Saf; 2003 Jan; 26(13):983-9. PubMed ID: 14583072
    [Abstract] [Full Text] [Related]

  • 37. Extreme hyperkalaemia caused by concomitant use of a NSAID and an ace inhibitor in an elderly patient.
    Rogulj D, Hauptfeld M, Iskra MS, Zorko VK, Strasek M.
    Arh Hig Rada Toksikol; 2010 Jun; 61(2):241-5. PubMed ID: 20587399
    [Abstract] [Full Text] [Related]

  • 38. Hyperkalaemia in Heart Failure-Pathophysiology, Implications and Therapeutic Perspectives.
    Llubani R, Vukadinović D, Werner C, Marx N, Zewinger S, Böhm M.
    Curr Heart Fail Rep; 2018 Dec; 15(6):390-397. PubMed ID: 30421355
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.